Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Wanhui Double-Crane Pharmaceutical is a specialized pharmaceutical manufacturer based in Beijing, China, and operates as a core subsidiary of China Resources Double-Crane Pharmaceutical. The company focuses on the development, production, and sale of chemical drugs, particularly those targeting chronic conditions such as cardiovascular disease and diabetes. Its extensive product portfolio includes widely used medications like amlodipine, valsartan, and metformin hydrochloride. Wanhui Double-Crane maintains advanced manufacturing facilities that comply with national GMP standards, ensuring high-quality production for the domestic Chinese market. As part of the larger China Resources Group, the company leverages significant resources for distribution and research. It plays a vital role in the parent company's strategy to provide affordable and effective healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Wanhui Double-Crane Pharmaceutical.